Lenvatinib 4mg capsules | Lenvatinib | Millionpharma DESCRIPTION Lenvatinib 4mg Lenvatinib 4mg is a multi-kinase inhibitor and antineoplastic agents. It is a type of targeted treatment which target the specific cancer cells and hence reduces side effects caused by affected cells. Lenvatinib 4mg inhibits the protein which promotes cell division by preventing the cancer cell development. PRESCRIBED FOR In adult, Lenvatinib 4mg tablet is indicated for the treatment of metastatic, progressive, radioactive Differentiated Thyroid cancer. Lenvatinib 4mg in combination with everolimus is indicated in patients for the treatment of advance Renal Cell Carcinoma following treatment before anti-angiogenic therapy. Lenvatinib 4mg is also indicated for the first line treatment in patients suffering with unresectable hepatocellular carcinoma. MECHANISM OF ACTION Lenvatinib is a tyrosine kinase inhibitor which has shown mainly ...